Xtl Biopharmaceuticals (XTLB) Net Income towards Common Stockholders (2011 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded Net Income towards Common Stockholders of -$6.97 million in the year ended Dec 31, 2025, compared with -$1.03 million a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Net Income towards Common Stockholders (2011 - 2024) Analysis & Trends
Starting with the year ended Dec 31, 2012, Xtl Biopharmaceuticals' Net Income towards Common Stockholders history includes 7 years.
- The figure for the year ended Dec 31, 2025 is the lowest annual Net Income towards Common Stockholders in data going back to the year ended Dec 31, 2012.
- Per Business Quant data, XTLB's Net Income towards Common Stockholders was -$1.03 million in the year ended Dec 31, 2024 and -$225,000 in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | -553,000.00 |
| Jun 30, 2024 | -421,000.00 |
| Mar 31, 2024 | -175,000.00 |
| Dec 31, 2023 | -284,000.00 |
| Sep 30, 2023 | -215,000.00 |
| Jun 30, 2023 | -163,000.00 |
| Mar 31, 2023 | -251,000.00 |
| Dec 31, 2022 | -748,000.00 |
| Sep 30, 2022 | -821,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | 72,000.00 |
| Dec 31, 2021 | 2.10 Mn |
| Sep 30, 2021 | -795,000.00 |
| Jun 30, 2021 | -1.15 Mn |
| Mar 31, 2021 | 286,000.00 |
| Dec 31, 2020 | -1.08 Mn |
| Sep 30, 2020 | -946,000.00 |
| Jun 30, 2020 | -1.11 Mn |
| Mar 31, 2020 | 173,000.00 |
API Access
Xtl Biopharmaceuticals Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();